70700-169 : Irinotecan Hydrochloide 20 mg/ml Intravenous Injection
NDC: | 70700-169 |
Labeler: | Xiromed LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Irinotecan Hydrochloide |
Dosage Form: | Intravenous Injection |
Application #: | ANDA212993 |
Rev. Date: |
NDC Package Codes:
- 70700-169-22: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (70700‑169‑22) > 2 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Irinotecan Hydrochloride
Dosage Strength:
- 20 mg/mL
Pharmaceutical Classes:
- Topoisomerase Inhibitor [EPC]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 68001-480 Irinotecan Hydrochloide 20 mg/ml Intravenous Injection by Bluepoint Laboratories
- 68083-381 Irinotecan Hydrochloide 20 mg/ml Intravenous Injection by Gland Pharma Limited
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 70700-168Next: 70700-170 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.